Back to directory listing

Professor David Lomas FMedSci

Job Title
Vice Provost (Health) and Head of UCL Medical School
School of Life and Medical Sciences
University College London (UCL)
Year elected



respiratory medicine, chronic obstructive pulmonary disease, antitrypsin deficiency, serpinopathies, conformational diseases

Section committee elected by

Medical and veterinary specialties and paediatrics

Professor David Lomas is Professor of Respiratory Medicine at the University of Cambridge. Although alpha 1 antitrypsin deficiency deficiency was first described in 1963, it was David Lomas who in a seminal publication in 1992 described the mechanism by which this protein is retained within the liver to cause cirrhosis. This involves a newly discovered type of protein-protein interaction termed loop-sheet polymerisation. This finding has had wide implications for other diseases characterised by beta strand linkage. These include Huntington’s disease, Alzheimer’s disease and the prion encephalopathies. These diseases may be grouped together as the conformational diseases and might be amenable to treatment with beta strand blockers.

Related Items

Bolder action needed for sustained change: 2019-20 diversity report published

Read more

Tribute to founder President Sir Peter Lachmann

Read more

5 things Fellows can do to support diversity in decision making

Read more

FB Twitter Instagram Youtube